 |
Principal
Investigator: Richard
Rosen, MD
and
Belinda Shirkey, MD
Enrollment
Status:
Open
Objective:
To compare visual acuity outcome among 3 groups of participants: those who are randomly assigned to receive standard care and those randomly assigned to receive one of two doses of intravitreal injection(s) of triamcinolone acetonide for treatment of macular edema associated with central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO).
Eligibility:
Contact Principal
Investigator/Coordinator.
Contact
Information:
- Principal
Investigators: Richard Rosen, MD and Belinda Shirkey, MD at (212) 979-4284
- Study Coordinator: Katy Tai, CR Manager (212) 979-4251
|